Evidence map›Paper›PMID 38002352›Full record

ArticleBiomolecules2023

A Moderate Decrease in ADAMTS13 Activity Correlates with the Severity of STEC-HUS.

Khadizha M Emirova, Olga M Orlova, Ekaterina M Chichuga, Alexander L Muzurov, Piotr P Avdonin, Pavel V Avdonin

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Biomolecules, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.2field-weighted citation impact, top 37% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 1 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 4 institutions in 1 country.

Khadizha M EmirovaDepartment of Pediatrics, A.I. Yevdokimov Moscow State University of Medicine and Dentistry, Moscow 127473, Russia.
Olga M OrlovaDepartment of Pediatrics, A.I. Yevdokimov Moscow State University of Medicine and Dentistry, Moscow 127473, Russia.ORCID 0000-0001-5217-3753
Ekaterina M ChichugaDepartment of Hospital Pediatrics, N.N. Burdenko Voronezh State Medical University, Voronezh 394036, Russia.
Alexander L MuzurovSt. Vladimir Children's City Clinical Hospital, Moscow 107014, Russia.
Piotr P AvdoninKoltsov Institute of Developmental Biology, Moscow 119334, Russia.
Pavel V AvdoninKoltsov Institute of Developmental Biology, Moscow 119334, Russia.ORCID 0000-0002-4138-1589
Koltzov Institute of Developmental Biology · RUMoscow State University of Medicine and Dentistry · RUSt. Vladimir Children's Moscow Clinical Hospital · RUVoronezh State Medical Academy named after N.N. Burdenko · RU

Funding

Russian Science Foundation 22-15-00409
6 · The paper itself

Abstract

Atypical hemolytic uremic syndrome (HUS) develops as a result of damage to the endothelium of microvasculature vessels by Shiga toxin produced by enterohemorrhagic

Indexed as

Acute Kidney InjuryAtypical Hemolytic Uremic SyndromePurpura, Thrombotic ThrombocytopenicShiga-Toxigenic Escherichia coliThrombotic MicroangiopathiesADAMTS13 ProteinChildHumansRenal Dialysisvon Willebrand FactorADAMTS13 ProteinADAMTS13 protein, humanvon Willebrand FactorADAMTS13childrenhemolytic uremic syndromeplateletsSTEC-HUSvon Willebrand factor

Identifiers

PMID38002352
PMCPMC10669222
OpenAlexW4388834256

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.